EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Hepatitis B virus (HBV) infection remains a global public health problem with changing
epidemiology due to several factors including vaccination policies and migration. This …
epidemiology due to several factors including vaccination policies and migration. This …
Hepatitis B virus reactivation associated with direct-acting antiviral therapy for chronic hepatitis C virus: a review of cases reported to the US Food and Drug …
SJ Bersoff-Matcha, K Cao, M Jason, A Ajao… - Annals of internal …, 2017 - acpjournals.org
Background: Direct-acting antiviral agents (DAAs) are used increasingly to treat hepatitis C
virus (HCV) infection. Reports were published recently on hepatitis B virus (HBV) …
virus (HCV) infection. Reports were published recently on hepatitis B virus (HBV) …
[PDF][PDF] Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: a systematic review and meta‐analysis
There is an increased awareness of hepatitis B (HBV) reactivation in chronic hepatitis C
(CHC) patients coinfected with HBV treated with pan‐oral direct‐acting antiviral agents …
(CHC) patients coinfected with HBV treated with pan‐oral direct‐acting antiviral agents …
Hepatitis due to reactivation of hepatitis B virus in endemic areas among patients with hepatitis C treated with direct-acting antiviral agents
C Wang, D Ji, J Chen, Q Shao, B Li, J Liu, V Wu… - Clinical …, 2017 - Elsevier
Hepatitis due to reactivation of hepatitis B virus (HBV) has been reported in patients treated
with direct-acting antiviral (DAA) agents for chronic hepatitis C virus infection. We performed …
with direct-acting antiviral (DAA) agents for chronic hepatitis C virus infection. We performed …
APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
T Kanda, GKK Lau, L Wei, M Moriyama, ML Yu… - Hepatology …, 2019 - Springer
In the direct-acting antiviral (DAA) era for hepatitis C virus (HCV) infection, sustained
virological response (SVR) is very high, but close attention must be paid to the possible …
virological response (SVR) is very high, but close attention must be paid to the possible …
Direct-acting antiviral treatment in adults infected with hepatitis C virus: reactivation of hepatitis B virus coinfection as a further challenge
A De Monte, J Courjon, R Anty, E Cua, A Naqvi… - Journal of Clinical …, 2016 - Elsevier
Use of direct-acting antiviral drugs (DAAs) greatly improves management of adults infected
with hepatitis C virus (HCV) whether patients are treatment-naive or unsuccessfully pre …
with hepatitis C virus (HCV) whether patients are treatment-naive or unsuccessfully pre …
Efficacy of ledipasvir and sofosbuvir treatment of HCV infection in patients coinfected with HBV
Background & Aims There have been reports of reactivation of hepatitis B virus (HBV)
infection during treatment of hepatitis C virus (HCV) infection with direct-acting antiviral …
infection during treatment of hepatitis C virus (HCV) infection with direct-acting antiviral …
[PDF][PDF] Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals
PS Belperio, TA Shahoumian, LA Mole, LI Backus - Hepatology, 2017 - Wiley Online Library
Reactivation of hepatitis B virus (HBV) has been reported in hepatitis C virus–infected
individuals receiving direct‐acting antiviral (DAA) therapy. The overall risk among patients …
individuals receiving direct‐acting antiviral (DAA) therapy. The overall risk among patients …
The oncologic burden of hepatitis C virus infection: a clinical perspective
HA Torres, TL Shigle, N Hammoudi… - CA: a cancer journal …, 2017 - Wiley Online Library
Answer questions and earn CME/CNE Chronic hepatitis C virus (HCV) infection affects
millions of people worldwide and is associated with cancer. Direct‐acting antivirals (DAAs) …
millions of people worldwide and is associated with cancer. Direct‐acting antivirals (DAAs) …
[HTML][HTML] 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
ML Yu, PJ Chen, CY Dai, TH Hu, CF Huang… - Journal of the Formosan …, 2020 - Elsevier
Hepatitis C virus (HCV) infection is a silent killer that leads to rapid progression of liver
cirrhosis and hepatocellular carcinoma (HCC). High prevalence of HCV infection has been …
cirrhosis and hepatocellular carcinoma (HCC). High prevalence of HCV infection has been …